See what your team can't.
The outside-in view your team is too close to run.
People you will never meet hold 50 percent of the buying influence. You know how the pitch lands with your champion. But, what do your brand and your go-to-market tell the people who actually decide, including the ones you will never meet? Start with the Brand Probe, the GTM Probe or both.
nunNEO.prob3 is the diagnostic. There are two ways into it: the Brand Probe, which asks why you are not being chosen, and the GTM Probe, which asks why the deal you are being chosen for still dies. Same instrument, same six dimensions, different question.
Most tools work on delivery. nunNEO works on the thinking behind it and is built for healthcare buying culture rather than adapted to it, and it reads the entire buying committee, not only the champion.
The Brand Probe
Start this if: your product holds up in a demo, but the brand is not giving the committee a reason to choose you, and you cannot see where it fails.
What it reads: how specifically you address your market, how clearly you are positioned, what separates you, how your language lands culturally, and whether the whole story holds together.
Not sure which diagnostic read is the right one?
Run Brand first if you are not being chosen. Run GTM first if you are being chosen and the deal still dies. Run both if you want the connection between them, which is where most stalled pipeline actually lives.
What happens after you start
-
You choose the diagnostic and complete payment. Scope, price and delivery window are fixed before anything begins.
-
You answer a structured intake covering positioning, audience, channel and commercial context. About ten minutes, no preparation needed.
-
You point us at the public-facing material already in market, and add supporting documents if you want to.
-
prob3 runs, the report goes through a compliance check, and it arrives by email.
What happens to your information
Client material is not used to train models.
Data handling runs through a single processing agreement at the model layer, so your IT reviewer gets one answer rather than several.
How the method is documented, reviewed and improved is governed internally, built against the control set of ISO/IEC 42001, the international standard for AI management systems. For more information, visit str3./ai.
Every version of the method carries a build record, so a report can be traced to the build that produced it and a finding that turns out to be wrong has a defined correction path. The discipline is borrowed from medical device quality practice. It is not a regulatory claim, and the diagnostic is not a regulated device.
Every report states what the method could not see.
Our security brief is published at str3.com/security.
For partners
Advisors, consultancies and referral partners can put a prob3 read in front of their own clients through nunNEO.bridg3, a single consent-scoped door. Access is requested, the scope is agreed in writing, and every share carries a record of what moved and why.
You cannot fix what you cannot name. Start with the read.
